Literature DB >> 27573725

Podocyte-actin dynamics in health and disease.

Luca Perico1, Sara Conti1, Ariela Benigni1, Giuseppe Remuzzi1.   

Abstract

Genetic studies of hereditary forms of nephrotic syndrome have identified several proteins that are involved in regulating the permselective properties of the glomerular filtration system. Further extensive research has elucidated the complex molecular basis of the glomerular filtration barrier and clearly established the pivotal role of podocytes in the pathophysiology of glomerular diseases. Podocyte architecture is centred on focal adhesions and slit diaphragms - multiprotein signalling hubs that regulate cell morphology and function. A highly interconnected actin cytoskeleton enables podocytes to adapt in order to accommodate environmental changes and maintain an intact glomerular filtration barrier. Actin-based endocytosis has now emerged as a regulator of podocyte integrity, providing an impetus for understanding the precise mechanisms that underlie the steady-state control of focal adhesion and slit diaphragm components. This Review outlines the role of actin dynamics and endocytosis in podocyte biology, and discusses how molecular heterogeneity in glomerular disorders could be exploited to deliver more rational therapeutic interventions, paving the way for targeted medicine in nephrology.

Entities:  

Mesh:

Year:  2016        PMID: 27573725     DOI: 10.1038/nrneph.2016.127

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  324 in total

1.  Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.

Authors:  W E Smoyer; P Mundel; A Gupta; M J Welsh
Journal:  Am J Physiol       Date:  1997-07

2.  The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Authors:  Björn Meijers; Rutger J H Maas; Ben Sprangers; Kathleen Claes; Ruben Poesen; Bert Bammens; Maarten Naesens; Jeroen K J Deegens; Ruth Dietrich; Markus Storr; Jack F M Wetzels; Pieter Evenepoel; Dirk Kuypers
Journal:  Kidney Int       Date:  2014-01-08       Impact factor: 10.612

3.  Synaptopodin expression in idiopathic nephrotic syndrome of childhood.

Authors:  T Srivastava; R E Garola; J M Whiting; U S Alon
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

4.  Functional consequences of integrin-linked kinase activation in podocyte damage.

Authors:  Vicente de Paulo Castro Teixeira; Simone Monika Blattner; Min Li; Hans-Joachim Anders; Clemens David Cohen; Ilka Edenhofer; Novella Calvaresi; Monika Merkle; Maria Pia Rastaldi; Matthias Kretzler
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

5.  Distribution of dystroglycan in normal adult mouse tissues.

Authors:  M Durbeej; M D Henry; M Ferletta; K P Campbell; P Ekblom
Journal:  J Histochem Cytochem       Date:  1998-04       Impact factor: 2.479

6.  N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.

Authors:  Terrel Sugar; Deborah J Wassenhove-McCarthy; A Wayne Orr; Jonette Green; Toin H van Kuppevelt; Kevin J McCarthy
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-02

7.  Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies.

Authors:  Monica Ceol; Emilia Tiralongo; Hans J Baelde; Daniela Vianello; Giovanni Betto; Annunziata Marangelli; Luciana Bonfante; Marialuisa Valente; Mila Della Barbera; Angela D'Angelo; Franca Anglani; Dorella Del Prete
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

8.  Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.

Authors:  Z Huang; L Zhang; Y Chen; H Zhang; Q Zhang; R Li; J Ma; Z Li; C Yu; Y Lai; T Lin; X Zhao; B Zhang; Z Ye; S Liu; W Wang; X Liang; R Liao; W Shi
Journal:  Cell Death Dis       Date:  2016-03-17       Impact factor: 8.469

9.  The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier.

Authors:  Nicolas Bisson; Julie Ruston; Marie Jeansson; Rachel Vanderlaan; W Rod Hardy; Jianmei Du; Samer M Hussein; Richard J Coward; Susan E Quaggin; Tony Pawson
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.

Authors:  Duane Delimont; Brianna M Dufek; Daniel T Meehan; Marisa Zallocchi; Michael Anne Gratton; Grady Phillips; Dominic Cosgrove
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more
  76 in total

1.  FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes.

Authors:  Balajikarthick Subramanian; Justin Chun; Chandra Perez-Gill; Paul Yan; Isaac E Stillman; Henry N Higgs; Seth L Alper; Johannes S Schlöndorff; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2020-01-10       Impact factor: 10.121

2.  Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.

Authors:  Michaele B Manigrasso; Richard A Friedman; Ravichandran Ramasamy; Vivette D'Agati; Ann Marie Schmidt
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-22

Review 3.  Are Pax proteins potential therapeutic targets in kidney disease and cancer?

Authors:  Edward Grimley; Gregory R Dressler
Journal:  Kidney Int       Date:  2018-04-21       Impact factor: 10.612

Review 4.  Sirtuins in Renal Health and Disease.

Authors:  Marina Morigi; Luca Perico; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2018-04-30       Impact factor: 10.121

5.  Protein kinase C ϵ stabilizes β-catenin and regulates its subcellular localization in podocytes.

Authors:  Michelle Duong; Xuejiao Yu; Beina Teng; Patricia Schroder; Hermann Haller; Susanne Eschenburg; Mario Schiffer
Journal:  J Biol Chem       Date:  2017-05-24       Impact factor: 5.157

6.  DAAM2 Variants Cause Nephrotic Syndrome via Actin Dysregulation.

Authors:  Ronen Schneider; Konstantin Deutsch; Gregory J Hoeprich; Jonathan Marquez; Tobias Hermle; Daniela A Braun; Steve Seltzsam; Thomas M Kitzler; Youying Mao; Florian Buerger; Amar J Majmundar; Ana C Onuchic-Whitford; Caroline M Kolvenbach; Luca Schierbaum; Sophia Schneider; Abdul A Halawi; Makiko Nakayama; Nina Mann; Dervla M Connaughton; Verena Klämbt; Matias Wagner; Korbinian M Riedhammer; Lutz Renders; Yoshichika Katsura; Dean Thumkeo; Neveen A Soliman; Shrikant Mane; Richard P Lifton; Shirlee Shril; Mustafa K Khokha; Julia Hoefele; Bruce L Goode; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2020-11-23       Impact factor: 11.025

7.  CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.

Authors:  Kayaho Maeda; Kotaro Otomo; Nobuya Yoshida; Mones S Abu-Asab; Kunihiro Ichinose; Tomoya Nishino; Michihito Kono; Andrew Ferretti; Rhea Bhargava; Shoichi Maruyama; Sean Bickerton; Tarek M Fahmy; Maria G Tsokos; George C Tsokos
Journal:  J Clin Invest       Date:  2018-07-09       Impact factor: 14.808

8.  Disruption of the exocyst induces podocyte loss and dysfunction.

Authors:  Deepak Nihalani; Ashish K Solanki; Ehtesham Arif; Pankaj Srivastava; Bushra Rahman; Xiaofeng Zuo; Yujing Dang; Ben Fogelgren; Damian Fermin; Christopher E Gillies; Matthew G Sampson; Joshua H Lipschutz
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

Review 9.  Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.

Authors:  Sanja Sever; Mario Schiffer
Journal:  Kidney Int       Date:  2018-04-17       Impact factor: 10.612

10.  A molecular mechanism explaining albuminuria in kidney disease.

Authors:  Bernhard Schermer; Thomas Benzing; Linus Butt; David Unnersjö-Jess; Martin Höhne; Aurelie Edwards; Julia Binz-Lotter; Dervla Reilly; Robert Hahnfeldt; Vera Ziegler; Katharina Fremter; Markus M Rinschen; Martin Helmstädter; Lena K Ebert; Hayo Castrop; Matthias J Hackl; Gerd Walz; Paul T Brinkkoetter; Max C Liebau; Kálmán Tory; Peter F Hoyer; Bodo B Beck; Hjalmar Brismar; Hans Blom
Journal:  Nat Metab       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.